Recent Activity

Loading...

ACHV

Achieve Life Sciences, Inc. · NASDAQ

Performance

+7.18%

1W

+5.49%

1M

+7.18%

3M

+13.1%

6M

+14.2%

YTD

-46.17%

1Y

Profile

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc. is based in Vancouver, Canada.

Technical Analysis of ACHV 2024-05-03

Overview:

In analyzing the technical indicators for ACHV over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.

Trend Analysis:

  • Moving Averages (MA): The 5-day Moving Average (MA) has been fluctuating around the c...
See more ...

Recent News & Updates